Across the 12-year period, antipsychotic
prescriptions in visits for anxiety
disorders increased from 10.6% (1996–
1999) to 21.3% (2004–2007). Over the
study period, the largest increase in antipsychotic
prescribing occurred
new patient visits. Antipsychotic prescribing
also significantly increased
privately insured visits and visits in which
neither antidepressants nor sedative/hypnotics
were prescribed. on anxiety disorder diagnoses, the largest
increase in antipsychotic edication
treatm ent was observed in visits for panic
disorder. Antipsychotic prescribing rose
from 6.9% (1996–1999) to 14.5% (2004–
2007) visits for anxiety disorders
in which there were no co-occurring diagnoses
with an indication approved by
the Food and Drug inistration for antipsychotic
edications